Brain Cancer
Cancer
Brain Cancer is treated with 14 medications in our database, including carmustine, Carmustine, temozolomide, Temozolomide, Gleostine, and 9 more. 9 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Heritage, Merck, Tri Source, Azurity, Medexus and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Brain Cancer treatment below.
What help exists for Brain Cancer
10
drugs indexed
4
with copay cards
4
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Brain Cancer
10 totalGliadel
carmustine
CARMUSTINE
Carmustine · Heritage
LOMUSTINE
lomustine
OJEMDA
TOVORAFENIB · Day One
🎟💙FeraBright
Ferumoxytol
🎟💙Temozolomide
Temozolomide · Merck
🎟💙TEMODAR
Temozolomide · Merck
🎟💙Gleostine
lomustine · NextSource Biotechnology
MultiHance
gadobenate dimeglumine · Bracco
GLEOLAN
AMINOLEVULINIC ACID HYDROCHLORIDE · Medexus
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Brain Cancer drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Showing 10 of 14 PA rules for Brain Cancer drugs. View individual drug pages for complete PA detail.